Healthcare - Medical - Diagnostics & Research - NASDAQ - IE
$ 1.37
-7.43 %
$ 15.6 M
Market Cap
-0.51
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
26.69%
EBIT
Estimate
61.95%
Net Income
Estimate
67.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Trinity Biotech plc
TRIB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TRIB
EBIT FORECAST
EBIT Forecast Chart TRIB
NET INCOME FORECAST
Net Income Chart TRIB